Internal Medicine, Infectious Disease · Oklahoma City, OK
NPI
1912382326
Since 2015
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
800 Stanton L Young Blvd Ste 7300
Oklahoma City, OK, 73104
Phone (405) 271-6122
Groups this clinician bills Medicare through
Medicare paid, 2024
$55K
586 services
Medicare patients, 2024
204
Average age 67
Drug cost, 2024
$1.2M
643 prescriptions
Company payments, 2025
$105
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Joseph Sassine was code 99233 (hospital e&m - subsequent), 269 times for 99 patients. In total Joseph Sassine billed 586 services in 11 codes, and Medicare paid $55K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-08-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 269 | 99 | $87.77 | $24K |
| 99232 Hospital E&M - Subsequent | Facility | 93 | 48 | $58.69 | $5,458 |
| 99223 Hospital E&M - Initial | Facility | 89 | 83 | $126.23 | $11K |
| 99215 Office E&M - Established | Facility | 56 | 41 | $102.53 | $5,742 |
| 99214 Office E&M - Established | Facility | 16 | 14 | $63.27 | $1,012 |
| 99222 Hospital E&M - Initial | Facility | 16 | 16 | $97.27 | $1,556 |
By year: 2022 $36K for 398 services; 2023 $55K for 575 services; 2024 $55K for 586 services.
Medicare prescription drug claims, 2024
In 2024, the drug Joseph Sassine prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 165 prescriptions and refills. In total Joseph Sassine wrote 643 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 165 | 165 | 19 | $660K |
| Azithromycin Generic | 35 | 37 | Under 11 | $1,163 |
| Imipenem-Cilastatin Sodium Imipenem/Cilastatin Sodium | 32 | 32 | Under 11 | $14K |
| Ethambutol Hcl Generic | 28 | 34 | Under 11 | $1,877 |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 27 | 27 | Under 11 | $95K |
| Cresemba Isavuconazonium Sulfate | 25 | 25 | Under 11 | $150K |
| Tigecycline Generic | 18 | 18 | Under 11 | $39K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 16 | 18 | Under 11 | $72.01 |
| Ceftriaxone Ceftriaxone Sodium | 15 | 15 | Under 11 | $7,146 |
| Descovy Emtricitabine/Tenofov Alafenam | 14 | 14 | Under 11 | $29K |
| Atorvastatin Calcium Generic | 14 | 20 | Under 11 | $55.89 |
| Rifampin Generic | 13 | 13 | Under 11 | $451 |
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | 12 | 12 | Under 11 | $56K |
| Ciprofloxacin Hcl Generic | 12 | 12 | Under 11 | $337 |
| Rifabutin Generic | 11 | 17 | Under 11 | $2,844 |
Brand drugs: 316 claims; generic drugs: 327 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Joseph Sassine $105 ($105 in general payments such as food, travel and fees) from 2 companies. The largest payer was Gilead Sciences, Inc. with $67.14.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 1 | $67.14 |
| Paratek Pharmaceuticals, Inc. | 1 | $37.94 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.